Cancer Registry Software Market (2033): AI-Powered Cancer Data Management, Electronic Health Records & Digital Healthcare Transformation

The Global Cancer Registry Software Market was valued at approximately USD 2.26 billion in 2025 and is projected to reach USD 3.91 billion by 2033, growing at a CAGR of 7.11% during 2026-2033. Market growth is driven by the increasing prevalence of cancer, rising demand for centralized cancer patient data management, growing adoption of electronic health records (EHRs), government initiatives supporting cancer surveillance programs, and increasing emphasis on improving cancer care outcomes through data-driven healthcare solutions.

Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/cancer-registry-software-market?sindhuri

Growth is supported by increasing adoption of standalone and integrated cancer registry software, cloud-based healthcare platforms, automated data collection, patient record management, and advanced analytics solutions. These technologies help healthcare providers streamline cancer data reporting, improve patient follow-up, support clinical research, monitor treatment outcomes, and enhance population-based cancer surveillance. Furthermore, integration with electronic health records, interoperability solutions, and automated reporting tools is improving data accuracy, operational efficiency, and healthcare decision-making.

North America remains a leading regional market, supported by established healthcare IT infrastructure, government-funded cancer surveillance programs, high adoption of electronic health records, and the presence of major healthcare technology providers. Asia-Pacific is expected to offer strong growth opportunities due to increasing cancer incidence, expanding healthcare infrastructure, rising digital health investments, and growing government initiatives to strengthen national cancer registries. Europe also represents a significant market, supported by cancer screening programs, healthcare digitalization, and increasing emphasis on population-based cancer research.
Cancer Registry Software Market: Competitive Intelligence

Siemens Healthineers, Onco, Inc., Elekta AB, C/Net Solutions, Rocky Mountain Cancer Data Systems, Electronic Registry Systems, Inc., McKesson Corporation, Ordinal Data, Inc., Conduent, Inc., IBM, and Himagine Solutions Inc. are key players in the market. Companies compete through software capabilities, electronic health record integration, data interoperability, reporting automation, analytics functionality, data security, and customized registry management solutions.

Siemens Healthineers focuses on healthcare IT and digital healthcare solutions, while Elekta emphasizes oncology information management and cancer data administration capabilities. Other market participants focus on improving cancer registry workflows, automated data abstraction, patient follow-up, data validation, and reporting capabilities. Key strategic priorities include expanding cloud-based registry platforms, integrating AI-powered analytics, strengthening patient data security, improving interoperability with hospital information systems, and supporting government-led cancer surveillance initiatives.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/cancer-registry-software-market?sindhuri

Recent Key Developments - United States & North America
✅ July 2026: AI-Powered Cancer Registry Abstraction: Carta Healthcare introduced Lighthouse for Oncology, extending its Hybrid Intelligence approach to cancer registry abstraction. The solution combines AI capabilities and human expertise to improve oncology data abstraction efficiency, enhance data quality, and reduce manual workloads for healthcare organizations.

✅ August 2026: Expansion of AI-Based Cancer Registry Platforms: Inspirata AI announced that five major academic cancer centers selected its AI-powered ONCO platform as their enterprise cancer registry solution. The platform supports automated cancer casefinding, real-time oncology data abstraction, and streamlined registry reporting, helping healthcare providers improve operational efficiency.

✅ September 2026: Cloud-Based Cancer Surveillance Modernization: The U.S. Centers for Disease Control and Prevention (CDC) advanced its National Program of Cancer Registries Cloud-Based Computing Platform. The initiative aims to streamline cancer data collection, editing, and storage while enabling real-time information sharing between healthcare providers and central cancer registries.

Recent Key Developments - Japan & Asia-Pacific
✅ April 2026: Expansion of Multi-Institutional Oncology Data Registries: Japan's J-CONNECT Consortium advanced the development of a multi-institutional oncology database using electronic medical records and hospital cancer registry information. The initiative integrates patient demographics, cancer staging, treatment information, laboratory results, and biomarkers to support real-world oncology research and evidence generation.

✅ March 2026: Digitalization of Japan's National Cancer Registration: Japan introduced a web-form input functionality within its Gan-Touroku Online System (GTOL), enabling healthcare institutions to submit cancer registration information through a secure online interface. The development supports more efficient digital reporting and improves accessibility for hospitals participating in the national cancer registry system.

✅ August 2026: Strengthening National Cancer Registry Data Governance: Japan's Ministry of Health, Labour and Welfare conducted its 37th Cancer Registry Subcommittee meeting, addressing the utilization and provision of national and prefectural cancer registry information, alongside revisions to national cancer registration manuals. These developments support standardized cancer data management and improved registry information utilization.

Recent Key Developments - Product & Technology Innovation
✅ July 2026: AI-Powered Oncology Data Abstraction: New cancer registry solutions incorporated hybrid intelligence, combining artificial intelligence with human validation to automate oncology data abstraction. These technologies aim to reduce manual data entry, improve data accuracy, and accelerate cancer registry reporting workflows.

✅ August 2026: Automated Cancer Casefinding and Real-Time Reporting: AI-enabled cancer registry platforms advanced automated case identification and oncology data extraction through machine learning, natural language processing, and integration with clinical information systems. These capabilities help hospitals identify reportable cancer cases more efficiently and reduce registry backlogs.

✅ September 2026: Cloud-Based Registry Infrastructure: Cloud-based cancer surveillance platforms gained attention through initiatives focused on centralized data collection, real-time reporting, and interoperability between hospitals, laboratories, and cancer registries. These technologies are expected to improve data accessibility, reporting efficiency, and cancer surveillance capabilities.

M&A / Strategic Activity
Recent strategic partnerships, technology collaborations, acquisitions, and ecosystem developments shaping the Cancer Registry Software Market:
Oracle Health - Expansion of cloud-based healthcare data management
Oracle Health continues to strengthen its healthcare technology portfolio through cloud-based electronic health records, clinical data management, and interoperability solutions. These capabilities support healthcare organizations in consolidating patient information and improving access to structured clinical data for cancer research and registry reporting.

IQVIA - Expansion of oncology real-world data capabilities
IQVIA is strengthening its oncology data and analytics ecosystem through collaborations with healthcare providers, pharmaceutical companies, and research organizations. Its real-world data capabilities support cancer research, treatment outcomes analysis, and evidence generation.

Flatiron Health - Oncology data and research collaborations
Flatiron Health continues to develop its oncology-focused real-world data platform through partnerships with cancer centers, healthcare providers, and life sciences organizations. These collaborations support the standardization of oncology information and improve the availability of clinical data for cancer research.
American College of Surgeons - National Cancer Database development
The American College of Surgeons continues to advance cancer data collection and quality improvement through its National Cancer Database and Commission on Cancer initiatives, encouraging hospitals to strengthen cancer reporting, data quality, and outcomes monitoring.

Healthcare IT ecosystem - Integration of cancer registry platforms
Cancer registry software providers are increasingly collaborating with hospitals, laboratories, electronic health record vendors, and public health agencies to improve automated data capture, interoperability, and standardized cancer reporting.

New Product/Technology Launches & Deployments
Recent innovations and technology deployments in the cancer registry software space:
Oracle Health - Interoperable Clinical Data Platforms
Cloud-based healthcare data platforms are supporting the integration of patient records, diagnostic information, treatment histories, and clinical documentation, helping healthcare organizations improve cancer data accessibility and registry workflows.

Flatiron Health - Oncology Data Platform
Flatiron Health's oncology-focused data solutions support the collection, structuring, and analysis of real-world cancer information, enabling researchers and life sciences companies to generate insights into treatment patterns and patient outcomes.

IQVIA - Oncology Real-World Data Analytics
IQVIA's oncology analytics capabilities help healthcare organizations and pharmaceutical companies analyze cancer treatment pathways, patient populations, clinical outcomes, and real-world evidence for oncology research.
Automated Cancer Case Abstraction - AI-Powered Data Capture
Artificial intelligence and natural language processing technologies are increasingly being applied to extract cancer-related information from electronic medical records, pathology reports, and clinical documents, reducing manual abstraction workloads.

Cloud-Based Cancer Registry Management - Centralized Reporting
Cloud-enabled registry platforms are improving centralized cancer data storage, remote accessibility, reporting efficiency, and coordination between hospitals, cancer centers, and population-based registries.
Interoperability-Based Cancer Reporting - Standardized Data Exchange
Modern registry solutions are increasingly incorporating standardized data exchange capabilities to facilitate the transfer of cancer information between electronic health records, laboratories, healthcare providers, and cancer surveillance systems.

R&D & Technological Advancements
AI-Powered Cancer Case Finding and Automated Abstraction
Research and development are increasingly focused on artificial intelligence and natural language processing technologies that automatically identify reportable cancer cases and extract relevant information from electronic medical records, pathology reports, and clinical documents, reducing manual workloads and improving registry accuracy.

Natural Language Processing for Oncology Data Extraction
Advancements in NLP are enabling cancer registry platforms to process unstructured clinical information, including cancer staging, tumor characteristics, treatment details, biomarkers, and patient outcomes, supporting faster and more consistent data abstraction.
Cloud-Based Cancer Registry Infrastructure
R&D is increasingly emphasizing cloud-native registry architectures that enable centralized data management, secure information exchange, remote access, and scalable reporting across multiple hospitals and cancer research institutions.

Interoperability and Standardized Data Exchange
Technology development is advancing integration with electronic health records, laboratory information systems, pathology platforms, and hospital information systems. Greater compatibility with FHIR and standardized cancer reporting formats is helping improve data consistency and information exchange.
Predictive Analytics and Real-World Evidence Generation
Cancer registry software providers are incorporating advanced analytics and real-world data capabilities to evaluate treatment patterns, survival rates, disease progression, and patient outcomes, supporting clinical research and healthcare decision-making.

Data Security and Privacy-Enhancing Technologies
R&D efforts are increasingly prioritizing encryption, role-based access controls, secure cloud infrastructure, and improved patient data governance to protect sensitive oncology information and support regulatory compliance.

Unlock & Gain Complete 360° Market Visibility:
https://www.datamintelligence.com/buy-now-page?report=cancer-registry-software-market?sindhuri

Segments Covered in the Global Cancer Registry Software Market:
By Type
The market is segmented into standalone software and integrated software. Integrated software is expected to dominate due to its ability to connect cancer registry systems with electronic health records (EHR), hospital information systems, and other healthcare platforms. Standalone software is also gaining adoption among smaller healthcare facilities and specialized cancer centers seeking dedicated solutions for cancer data collection, management, and reporting.

By Deployment Model
The market includes on-premise and cloud-based deployment models. Cloud-based solutions are gaining significant adoption due to their scalability, cost-effectiveness, remote accessibility, and real-time data-sharing capabilities. On-premise solutions continue to be preferred by healthcare organizations that prioritize direct data control, customized infrastructure, and enhanced internal security management.

By Database
The market is segmented into commercial databases and public databases. Commercial databases are gaining traction due to their advanced analytical capabilities, structured cancer data management, and integration with specialized reporting platforms. Public databases remain important for cancer surveillance, epidemiological research, population-based cancer studies, and standardized reporting across healthcare institutions.

By End User
The market comprises hospitals, clinics, and ambulatory surgical centers. Hospitals are expected to dominate due to their high volume of cancer diagnoses, availability of specialized oncology departments, and increasing need for comprehensive cancer data management and regulatory reporting. Clinics and ambulatory surgical centers are also adopting registry software to improve patient tracking, treatment documentation, and cancer care coordination.

By Region
North America
North America is expected to dominate the market due to its advanced healthcare IT infrastructure, established cancer surveillance programs, increasing adoption of electronic health records, and growing emphasis on cancer data standardization and reporting. Government initiatives and investments in cancer research further support regional market growth.

Europe
Europe represents a significant market supported by established cancer registries, increasing investments in healthcare digitization, and growing emphasis on population-based cancer surveillance. The adoption of standardized cancer reporting systems and cross-border healthcare data initiatives is also supporting regional demand.

South America
South America is witnessing growing adoption of cancer registry software due to increasing awareness of cancer surveillance, expanding healthcare IT infrastructure, and government initiatives aimed at improving cancer diagnosis and reporting. Brazil and Argentina are among the important markets supporting regional development.

Asia-Pacific
Asia-Pacific is expected to experience significant growth due to rising cancer incidence, expanding healthcare infrastructure, increasing digital health investments, and growing government initiatives for cancer registration. Countries such as China, India, and Japan are strengthening cancer surveillance and data management capabilities.

FAQ's
Q1: What is the current market size of the Cancer Registry Software Market and its future outlook?
Ans: The global Cancer Registry Software Market was valued at approximately US$ 2.26 billion in 2025 and is projected to reach US$ 3.91 billion by 2033.

Q2: How fast is the Cancer Registry Software Market expected to grow during the forecast period?
Ans: The market is projected to expand at a CAGR of approximately 7.11% from 2026 to 2033, driven by the increasing prevalence of cancer, growing adoption of electronic health records, favorable government initiatives, and rising demand for digital cancer data management solutions.

Q3: Which region leads the Cancer Registry Software Market?
Ans: North America dominates the global Cancer Registry Software Market, supported by its advanced healthcare IT infrastructure, high adoption of electronic health records, government funding for cancer registry programs, and the presence of established cancer registry software providers. Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Contact Us -
Company Name: DataM Intelligence Contact
Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.